Dec 15 (Reuters) - Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi (SASY.PA), opens new tab to develop therapies for autoimmune diseases in a ...

The Australian wife of US rapper Kanye West unveiled the long-teased project, BIO POP (THE ORIGIN), in the South Korean capital on Thursday, shocking fans with an exhibition filled with 'human ...

We now know what Bianca Censori’s BIO POP (THE ORIGIN) is, and furniture does play a key part after all. Thursday (Dec. 11), Censori launched the previously teased project in Seoul, revealing—as had ...

The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a multistep method for transfecting mouse ...

The University of Pittsburgh will borrow funds through a federal tax credit program to partially fund construction of BioForge, a $250 million cell and gene therapy manufacturing facility in Hazelwood ...

Securities and Exchange Commission filings indicate that Oxford Finance LLC acquired 1.62 million common shares, representing 16.5% ownership in the clinical-stage company. Oxford Finance, the ...

At this point, Project Diablo 2 has easily become my preferred way to play Blizzard's classic. While D2 remains one of the best RPGs of all time, and Diablo 2 Resurrected gives it a fresh coat of ...

The MarketWatch News Department was not involved in the creation of this content. Targeting the Root Causes of Aging Demonstrates Powerful Anti-Cancer Activity Across Multiple Tumor Models MIAMI BEACH ...

MIAMI BEACH, Fla., Nov. 25, 2025 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company pioneering therapies focusing on Treating Diseases of Aging and Treating Aging as Disease™, today ...

The IRS has ended the Direct File program, which let some taxpayers file their annual returns for free using software developed by the government. Many tax preparation companies opposed this, as did ...

An illustration of a protein created by Accipiter Bio that has two active sites, shown in light and darker green, that can simultaneously bind two targets. (Accipiter Bio Image) A Seattle biotech ...